AU2001276674A1 - Diagnosis of liver cancer based on detecting sssa1 protein - Google Patents

Diagnosis of liver cancer based on detecting sssa1 protein

Info

Publication number
AU2001276674A1
AU2001276674A1 AU2001276674A AU7667401A AU2001276674A1 AU 2001276674 A1 AU2001276674 A1 AU 2001276674A1 AU 2001276674 A AU2001276674 A AU 2001276674A AU 7667401 A AU7667401 A AU 7667401A AU 2001276674 A1 AU2001276674 A1 AU 2001276674A1
Authority
AU
Australia
Prior art keywords
diagnosis
protein
sssa1
detecting
liver cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001276674A
Inventor
Patrizia Pontisso
Felice Sitia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
XEPTAGEN SpA
Original Assignee
XEPTAGEN SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by XEPTAGEN SpA filed Critical XEPTAGEN SpA
Publication of AU2001276674A1 publication Critical patent/AU2001276674A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57438Specifically defined cancers of liver, pancreas or kidney

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Radiation Diagnosis (AREA)

Abstract

This invention relates to a method for diagnosing hepatocellular carcinoma (HCC) based on the detection of SCCA1 protein and, in particular to an immunohistochemical method for diagnosis of hepatocellular carcinoma.
AU2001276674A 2000-07-28 2001-07-23 Diagnosis of liver cancer based on detecting sssa1 protein Abandoned AU2001276674A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2000PD000192A IT1317355B1 (en) 2000-07-28 2000-07-28 POLYCLONAL ANTIBODIES.
ITPD2000A00192 2000-07-28
PCT/IT2001/000393 WO2002010757A2 (en) 2000-07-28 2001-07-23 Diagnosis of liver cancer based on detecting sssa1 protein

Publications (1)

Publication Number Publication Date
AU2001276674A1 true AU2001276674A1 (en) 2002-02-13

Family

ID=11452040

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001276674A Abandoned AU2001276674A1 (en) 2000-07-28 2001-07-23 Diagnosis of liver cancer based on detecting sssa1 protein

Country Status (6)

Country Link
EP (1) EP1307747B1 (en)
AT (1) ATE448483T1 (en)
AU (1) AU2001276674A1 (en)
DE (1) DE60140451D1 (en)
IT (1) IT1317355B1 (en)
WO (1) WO2002010757A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD20030264A1 (en) 2003-10-30 2005-04-30 Xeptagen Spa HIGHLY SPECIFIC DIAGNOSIS METHOD FOR NEOPLASIA
CN107907686A (en) * 2017-11-22 2018-04-13 南宁科城汇信息科技有限公司 A kind of immunohistochemistry detects NAP2 expressions in liver cancer and cancer beside organism
CN112129941A (en) * 2020-09-22 2020-12-25 武汉生之源生物科技股份有限公司 Chemiluminescence kit for detecting squamous cell carcinoma antigen

Also Published As

Publication number Publication date
EP1307747A2 (en) 2003-05-07
WO2002010757A3 (en) 2002-08-22
ATE448483T1 (en) 2009-11-15
IT1317355B1 (en) 2003-06-16
DE60140451D1 (en) 2009-12-24
ITPD20000192A0 (en) 2000-07-28
ITPD20000192A1 (en) 2002-01-28
EP1307747B1 (en) 2009-11-11
WO2002010757A2 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
WO2002035232A3 (en) Method for detecting ovarian cancer based on human kallikrein 6 (hk6)
DK1071710T4 (en) Genomic sequence of the 5-lipoxygenase activation protein (FLAP), polymorphic markers therein and methods for detecting asthma
AU1740700A (en) Method and apparatus for performing a lateral flow assay
EP1090291A4 (en) Method for early diagnosis of, and determination of prognosis in, cancer
WO2006038208A3 (en) Agents capable of downregulating an msf-a - dependent hif-1α and use thereof in cancer treatment
WO2003026493A3 (en) Diagnosis and treatment of diseases caused by mutations in cd72
MXPA03007037A (en) Modified psma ligands and uses related thereto.
HK1074251A1 (en) Diagnosis of hepatocellular carcinoma
EP1070244A4 (en) Electronic techniques for analyte detection
TW200512457A (en) Method of diagnosing SARS corona virus infection
GB9827228D0 (en) Cancer detection method and reagents
AU2002338348A1 (en) Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
AU3000701A (en) Method and device for detecting and quantifying biomolecules
WO2005043165A3 (en) Specific method for cancer detection
WO2005113838A3 (en) Detection of protein translocation by beta-galactosidase reporter fragment complementation
AU2003280694A1 (en) Urothelial cancer tumor marker
DK0972782T3 (en) Monoclonal antibody recognizing the oligosaccharide N-glycolylated galactose-glucose-sialic acid in malignant tumors and preparations containing it
WO1997029199A3 (en) Prostate specific antigen peptides and uses thereof
AU2002341488A1 (en) Method for detecting progredient chronic dementia, and associated peptides and detection reagents
AU2001276674A1 (en) Diagnosis of liver cancer based on detecting sssa1 protein
AU5144696A (en) Method of examining household dust
WO2007033367A3 (en) Salivary protein and rna for breast cancer detection
AU2000264217A1 (en) Method for detecting serum and for determining the quality thereof, and corresponding devices
WO2005041631A3 (en) Endotheliase-1 ligands
WO2002004952A3 (en) Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors